Marina Bentivoglio is Professor of Histology at the University of Verona, Italy. She graduated in Medicine at the Catholic University of Rome, Italy, where she also did her residency in Neurology. After her training in clinical neurology and in neuropathology, she has focused on experimental approaches to the neurobiology of disease. Her research focuses on neural-immune interactions in neuroinflammatory and neurodegenerative conditions, aging, sleep disorders. She has published over 185 scientific articles and 50 chapters in books.
She served as Secretary General of the International Brain Research Organization (IBRO) and as President of the Italian Society of Neuroscience (SINS) and in Committees of the Federation of the European Neuroscience Societies (FENS). She serves in the Council of the Rita Levi-Montalcini Foundation for the education of African women, and in the “Neurobiology Educational Task Force” of the International League against Epilepsy (ILAE). She is a member of the Academia Europaea, foreign member of the Academy of Medical Sciences of Argentina, and other scientific academies. She is actively engaged in the training of young investigators and in activities to foster international cooperation in the neurological sciences, with special reference to countries with limited resources. She has participated as lecturer/instructor in numerous courses and schools in neuroscience in Europe, Africa, Latin America.
I am a movement disorders neuropsychiatrist. My research is primarily focused on neuroimaging and dopamine, especially in people with Tourette syndrome and Parkinson disease. I have also developed methods for structural imaging volumetry, analysis of brain images in nonhuman species, pharmacological fMRI (phMRI), and statistical analysis of anatomy-function relationships in deep brain stimulation (DBS).
Interested in: Perception and action - Affordances - Social and relational affordances; Language grounding in sensorimotor processes; Impact of language on categorization and sense of body; Categorization and conceptualization. Using mostly experimental laboratory methods (behavioral and kinematics studies), but also computer simulations (neural networks).
I did my PhD at King's College London in the Lab of Prof J.M. Littleton working on adaptive mechanisms underlying drug dependence. I demonstrated adaptive changes in the number of DHP sensitive VOCC following chronic exposure to central depressant drugs and showed that these changes were associated with genetic vulnerability to drug dependence.
I undertook post-doc training at the Clinical Research Centre Harrow, UK before joining the laboratory of Prof Nigel Holder at The Randall Institute, KCL and moving with him to UCL in 1998. Whilst at KCL and UCL I used zebrafish as a genetic model system for analysis of mechanisms underlying development.
Since 2000, I have been a Lecturer in Molecular Genetics in the School of Biological Sciences QMUL. Our work combines the two areas of my expertise: Molecular mechanisms underlying drug dependence and zebrafish as a developmental genetic model system. We have developed behavioural assays of drug seeking, compulsive drug seeking and relapse in zebrafish and are establishing lines of fish in which to explore the genetics contributing to these behaviours.
I was awarded my PhD in Psychology from Warwick University in 2003. My PhD topic was language and memory in Williams syndrome. I then completed a short post-doc at Bristol Uni investigating similar issues in Down syndrome, followed by a post-doc at Oxford investigating eye-movements in autism. Since 2007 I have been a research fellow at Macquarie University. My current research uses magnetoencephalography (MEG) to investigate the neural basis of language and auditory processing in autism.
M.D., Ph.D. He has a deep knowledge of and experience in electrophysiology in monkeys (single neurons recordings) and humans (transcranial magnetic stimulation, study of spinal excitability and brain imaging). His current research include the study of the relationships between action and language and the realization of brain-computer interfaces specifically designed for human use.
Since completing my Ph.D. in Italy in Psychology my research interests have centered on Memory and Aging, emotion and cognition, binding and Source monitoring. I am currently a researcher at the University of Chieti, Italy where I teach Cognitive Psychology and Psychology of memory and aging.
Claire Fletcher-Flinn has more than 24 years of experience as a university researcher and teacher, and is a registered Educational Psychologist. Her research interests include the processes of learning to read, early literacy, and dyslexia. She was awarded a Visiting Fellow at the University of Oxford, and was the recipient of a Japanese Society for the Promotion of Science (JSPS) Invitation Fellowship.
Dr. Tamàs Fülöp is Assistant Director of the Age Research Centre and Full Professor within the Faculty of Medicine and Health Sciences at the Université de Sherbrooke in Quebec, Canada. He is also Head of the Immune Inflammation Laboratory and Medical Director of the Memory Clinic.
M.D: From the Unversity of Geneva.
His postdoctoral research was in the biochemistry of connective tissues, and his PhD is in immunology and gerontology. His research interest is aging in relation to immunity.
Reader in Neuroscience at King's College London, Institute of Psychiatry, Psychology & Neuroscience.
Beth is a Professor of Psychology at the University of York, UK. Her research seeks to understand the neural basis of semantic cognition and language, and disorders affecting these aspects of cognition. She uses multiple neuroscientific methods, including neuropsychology, neuroimaging (MEG, fMRI) and brain stimulation to investigate how concepts are represented and flexibly retrieved.
N Landsberger is associate professor in Molecular Biology at the University of Insubria (Italy).
Even though her previous research domain was in chromatin structure and gene transcription, actually the research activity supervised by N.L. is exclusively dedicated to MECP2 and CDKL5 related disorders, focusing on the molecular roles of the two proteins, the signaling pathways controlling their activity, the identification of target genes and the development of novel cellular and animal models.